The global house dust mite allergy drugs market is anticipated to grow at a significant CAGR 13.2% during the forecast period (2022-2028). House dust mite allergy is an allergic reaction to tiny bugs that commonly live in house dust. Symptoms include stuffy, runny, sneezing, itchy nose as well as irritated eyes. Adding to this, in some cases, eczema and asthma can also be triggered due to dust mite allergy. These symptoms are reported to often get worse when the individual comes in close contact with disturbed dust. The major factors attributed to the growth of the market include the growing prevalence of dust mite allergy all over the globe. The allergy also depends on various factors such as family history and age. The treatment options include taking decongestants, antihistamines, and corticosteroids. Thus, in order to control the symptoms of this allergy among global population, the demand for house dust mite allergy drugs is likely to grow in the future years.

There are various types of dust mite allergy drugs available in the market such as Acarovac Quattro, AllerDM, and others. However, the AllerDM drug is likely to register significant demand commercially. These drugs are regulated by the regulatory approvals of various regions such as European Medical Association (EMA), the United States Food and Drugs Administration (US FDA), Conformité Européene (CE) and other regulatory authorities. Some key players operating in the market include Merck & Co., Inc., Allergy Therapeutics plc, and Anergis SA, among others. 

Market Coverage

• The market number available for – 2021-2028

• Base year- 2021

• Forecast period- 2022-2028

• Segment Covered- 

o By Product

o By Application

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape:  Merck & Co., Inc., Allergy Therapeutics plc, and Anergis SA, among others.

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global House Dust Mite Allergy Drugs Market Report by Segment

By Product

• Acarovac Quattro

• AllerDM

• Others

By Application

• Hospital

• Clinic

• Others

Global House Dust Mite Allergy Drugs Market Report by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa